Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Asset Utilization Ratio (2016 - 2025)

Standard Biotools (LAB) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.31 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 127.91% to 0.31 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.31, a 127.91% increase, with the full-year FY2024 number at 0.37, up 25.1% from a year prior.
  • Asset Utilization Ratio was 0.31 for Q3 2025 at Standard Biotools, up from 0.3 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.5 in Q2 2021 to a low of 0.14 in Q3 2024.
  • A 5-year average of 0.32 and a median of 0.3 in 2025 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 55.11% in 2024, then soared 127.91% in 2025.
  • Standard Biotools' Asset Utilization Ratio stood at 0.47 in 2021, then plummeted by 48.08% to 0.24 in 2022, then soared by 31.99% to 0.32 in 2023, then fell by 16.03% to 0.27 in 2024, then grew by 14.81% to 0.31 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Asset Utilization Ratio are 0.31 (Q3 2025), 0.3 (Q2 2025), and 0.28 (Q1 2025).